ONO-4059-10:Multicenter, Placebo-controlled, Randomized, Double-blind, Phase 3 Study in Patients With Steroid-resistant Pemphigus
Status: Recruiting
Location: See all (20) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY
ONO-4059-10:Multicenter, placebo-controlled, randomized, double-blind, Phase 3 study in patients with steroid-resistant pemphigus
Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Healthy Volunteers: f
View:
• Patients with a diagnosis of pemphigus
• Patients with a re-increase in the pemphigus disease area index (PDAI) score before oral corticosteroid tapering to 10mg/day of prednisolone (PSL) equivalent
Locations
Other Locations
Japan
Ichinomiya Municipal Hospital
NOT_YET_RECRUITING
Aichi
Nagoya City University Hospital
NOT_YET_RECRUITING
Aichi
Kurume University Hospital
NOT_YET_RECRUITING
Fukuoka
Fukushima Medical University Hospital
RECRUITING
Fukushima
Hokkaido University Hospital
RECRUITING
Hokkaido
Kagoshima University Hospital
RECRUITING
Kagoshima
St.Marianna University School of Medicine Hospital
RECRUITING
Kanagawa
Tokai University Hospital
RECRUITING
Kanagawa
Yokohama City University Hospital
RECRUITING
Kanagawa
University Hospital Kyoto Prefectural University of Medicine
RECRUITING
Kyoto
Niigata University Medical & Dental Hospital
RECRUITING
Niigata
Kawasaki Medical School Hospital
NOT_YET_RECRUITING
Okayama
Kindai university hospital
RECRUITING
Osaka
Osaka Metropolitan University Hospital
RECRUITING
Osaka
Saitama Medical Center
RECRUITING
Saitama
Jichi Medical University Hospital
RECRUITING
Tochigi
Keio University Hospital
RECRUITING
Tokyo
Tokyo Medical and Dental University Hospital
RECRUITING
Tokyo
Tokyo Women'ｓ Medical University Hospital
NOT_YET_RECRUITING
Tokyo
Yamagata University Hospital
NOT_YET_RECRUITING
Yamagata
Contact Information
Primary
Ono Pharmaceutical Co., Ltd.
clinical_trial@ono-pharma.com
Time Frame
Start Date: 2022-08-15
Estimated Completion Date: 2029-03-31
Participants
Target number of participants: 34
Treatments
Active_comparator: ONO-4059
Placebo_comparator: Placebo
Related Therapeutic Areas
Sponsors
Leads: Ono Pharmaceutical Co. Ltd